Kim Young Eun, Kim Yun Joong, Hwang Hee Sung, Ma Hyeo-Il
Department of Neurology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, South Korea; Hallym Neurological Institute, Hallym University, South Korea.
Department of Neurology, Yongin Yonsei University Hospital, Yonsei University, South Korea.
Parkinsonism Relat Disord. 2020 Nov;80:120-126. doi: 10.1016/j.parkreldis.2020.09.032. Epub 2020 Sep 21.
To test the hypothesis that REM sleep behavior disorder (RBD) in early Parkinson's disease (PD) predicts rapid progression of dopaminergic denervation.
123I-FP-CIT single photon emission computed tomography (SPECT) scans were performed sequentially at baseline, 1 year, 2 years, and 4 years in 416 de novo patients with PD. RBD screening questionnaire scores >5 at baseline placed the participant in the likely-RBD group. Temporal changes in the specific binding ratio (SBR; caudate, putamen. sum of both, striatum) were compared between the likely-RBD and the non-likely-RBD groups for more or less affected striatum with a repeated measure ANOVA.
Likely-RBD was reported in 37.7% of the drug-naïve PD patients at baseline. The likely-RBD and non-likely-RBD groups did not have significant differences in the baseline clinical features including gender, age, disease duration, UPDRS motor score, and striatal SBR. Striatal SBR decreased significantly over four years in both groups (P < .001). In the analysis of a more affected striatum, striatal SBR decreased significantly faster in the likely-RBD group than in the non-likely-RBD group (P < .05 for all), whereas it was not statistically significant for the less affected striatum. The mean striatal SBR value (mean value of both striata), especially the caudate SBR, indicated greater acceleration of denervation in the likely-RBD group than in the non-likely-RBD group over time (P < .05).
Likely-RBD in PD predicts accelerating dopaminergic denervation, thereby implicating it as a marker for a poor prognosis or distinctive subtype in PD.
检验早期帕金森病(PD)中的快速眼动睡眠行为障碍(RBD)预示着多巴胺能神经支配快速进展这一假设。
对416例新发PD患者在基线、1年、2年和4年时依次进行123I-FP-CIT单光子发射计算机断层扫描(SPECT)。基线时RBD筛查问卷得分>5分的参与者被归入可能患有RBD组。采用重复测量方差分析比较可能患有RBD组和非可能患有RBD组中受影响程度或多或少的纹状体的特异性结合率(SBR;尾状核、壳核、两者之和、纹状体)的时间变化。
基线时,37.7%的未用药PD患者报告可能患有RBD。可能患有RBD组和非可能患有RBD组在基线临床特征(包括性别、年龄、病程、UPDRS运动评分和纹状体SBR)方面无显著差异。两组纹状体SBR在4年中均显著下降(P<0.001)。在对受影响更严重的纹状体的分析中,可能患有RBD组纹状体SBR下降明显快于非可能患有RBD组(所有P<0.05),而对受影响较轻的纹状体则无统计学意义。随着时间推移,纹状体SBR的均值(双侧纹状体的均值),尤其是尾状核SBR,表明可能患有RBD组的神经支配去神经化加速程度大于非可能患有RBD组(P<0.05)。
PD中可能患有RBD预示着多巴胺能神经支配去神经化加速,因此意味着它是PD预后不良或独特亚型的一个标志物。